E
Emily M. Eichenberger
Researcher at Duke University
Publications - 28
Citations - 4556
Emily M. Eichenberger is an academic researcher from Duke University. The author has contributed to research in topics: Medicine & Internal medicine. The author has an hindex of 7, co-authored 18 publications receiving 2741 citations. Previous affiliations of Emily M. Eichenberger include Cornell University.
Papers
More filters
Journal ArticleDOI
Staphylococcus aureus Infections: Epidemiology, Pathophysiology, Clinical Manifestations, and Management
TL;DR: This review comprehensively covers the epidemiology, pathophysiology, clinical manifestations, and management of S. aureus as a leading cause of bacteremia and infective endocarditis as well as osteoarticular, skin and soft tissue, pleuropulmonary, and device-related infections.
Journal ArticleDOI
Methicillin-resistant Staphylococcus aureus: an overview of basic and clinical research.
Nicholas A Turner,Batu K. Sharma-Kuinkel,Stacey A. Maskarinec,Emily M. Eichenberger,Pratik Shah,Manuela Carugati,Manuela Carugati,Thomas L. Holland,Vance G. Fowler,Vance G. Fowler +9 more
TL;DR: An overview of basic and clinical MRSA research is provided and the expansive body of literature on the epidemiology, transmission, genetic diversity, evolution, surveillance and treatment of MRSA is explored.
Journal ArticleDOI
Loss of the FAT1 Tumor Suppressor Promotes Resistance to CDK4/6 Inhibitors via the Hippo Pathway
Zhiqiang Li,Pedram Razavi,Pedram Razavi,Qing X. Li,Weiyi Toy,Bo Liu,Christina Ping,Wilson Hsieh,Francisco Sanchez-Vega,David N Brown,Arnaud Da Cruz Paula,Luc G. T. Morris,Pier Selenica,Emily M. Eichenberger,Ronglai Shen,Nikolaus Schultz,Neal Rosen,Neal Rosen,Maurizio Scaltriti,Edi Brogi,José Baselga,Jorge S. Reis-Filho,Sarat Chandarlapaty,Sarat Chandarlapaty +23 more
TL;DR: A tumor suppressor function of Hippo signaling in ER+ breast cancer is uncovered and FAT1 loss is established as a mechanism of resistance to CDK4/6i.
Journal ArticleDOI
Epidemiology and Mechanisms of Resistance of Extensively Drug Resistant Gram-Negative Bacteria
TL;DR: The mechanisms and global epidemiology of antibiotic resistance in some of the most clinically important resistance phenotypes, including carbapenem resistant Enterobacteriaceae, extensively drug resistant (XDR) Pseudomonas aeruginosa, and XDR Acinetobacter baumannii are reviewed.
Journal ArticleDOI
Positive follow-up blood cultures identify high mortality risk among patients with Gram-negative bacteraemia
Stacey A. Maskarinec,Lawrence P. Park,Felicia Ruffin,Nicholas A Turner,Nimish Patel,Emily M. Eichenberger,D. van Duin,Thomas P. Lodise,Vance G. Fowler,Joshua T. Thaden +9 more
TL;DR: Rates of positive FUBCs were high and identified patients at increased risk for mortality, and clinical variables can identify patients at high risk for positive F UBCs.